e-Connect Logo
Issue:  November 2011 •  Archive  •  Subscribe •  Unsubscribe
In This Edition Featured Article Featured CE
•  Editor's Notebook
•  Counseling Pearls
•  It's the Law
•  Clinical Corner
•  Consult Your Pharmacist
•  Educational Spotlight
•  Quick Poll
      –Off-label Use
  Photo Labeling Guidelines for Antipsychotics During Pregnancy
The labeling for all antipsychotics will be updated to include an enhanced pregnancy section.
  Photo Drug Treatment of Addictive Diseases
Without intervention, drug and alcohol addiction is a chronic and potentially fatal disease.

NEW! Follow us on
Fb Logo  Tw Logo

Editor's Notebook
Now It's Your Turn

Pharmacists have actively answered the polls posted monthly on our Web site. Your opinion really does count!
Counseling Pearls
Photo OCD and Its Treatment

Obsessive-compulsive disorder is an extremely disabling disease involving recurrent obsessions and/or compulsions that consume a large amount of time. Treatment rarely resolves all symptoms, but improvements can occur through the use of psychotherapy and SSRIs.
Photo Pharmacogenetics and Depression: Realized Dream or Great Expectation?

With research in this area expanding and the FDA supporting pharmacogenomic initiatives, the current dream of personalized medicine for depression may soon become a reality. Individualized therapy would revolutionize treatment and allow optimization of drug efficacy.
It's the Law
FDA Tries to Compound the Compounding Rules

The FDA has continually questioned the traditional compounding of veterinary drugs, as exhibited by the case of the Florida pharmacy and the death of 21 polo horses.
Clinical Corner
Photo Pharmacotherapy of Major Depressive Disorder

Antidepressants are the mainstay of treatment for this mental disorder, which is characterized by an all-encompassing low mood accompanied by poor self-esteem and loss of interest or pleasure in normally enjoyable activities (anhedonia).
Photo Bipolar II Disorder in Adults: A Review of Management Options

Bipolar I and bipolar II differ in the presentation of mood variations. The course of bipolar II is less well studied, and patients present with one or more episodes of major depression with at least one hypomanic episode.


Consult Your Pharmacist
Advising Patients With Acne

Benzoyl peroxide and salicylic acid are among the OTC products found effective for treating this common dermatologic condition.
Educational Spotlight
Pharmacists' Role When Plan A Fails: Patient Considerations in the Dispute Over Plan B and Emergency Contraception

Beliefs aside, pharmacists should present a complete and accurate summary of available facts to their patients.
Iodine Nutrition and the Impact of Dietary Sodium Reduction

Iodine deficiency is a leading cause of preventable childhood brain damage and a serious public health problem.
FDA Launches "Sharps" Web site
Bethesda, MD — The FDA has launched a new Web site, Needles and Other Sharps (Safe Disposal Outside of Health Care Settings), to help educate patients and caregivers on the safe disposal of needles and other so-called "sharps" that are used at home, at work, and while traveling. Sharps are medical devices with sharp points or edges that can puncture or cut skin such as hypodermic needles, syringes, and lancets. With more medical conditions such as diabetes, cancer, and arthritis being managed at home, the number of sharps used outside of hospitals and doctors' offices is increasing, with an estimated 3 billion used in U.S. homes each year. Many sharps end up in household and public trash cans or flushed down toilets after being used, and this kind of improper disposal puts people at risk for needle stick injuries or infection with viruses such as HIV and hepatitis B/C.
Ranbaxy Planning to Manufacture Generic Lipitor
New Delhi, India Ranbaxy Laboratories Ltd. may resolve a dispute with U.S. authorities in time to begin selling a generic of Pfizer's cholesterol-lowering drug Lipitor (atorvastatin) at the end of November. Lipitor is the world's best-selling drug, generating $10.7 billion in 2010. A legal settlement with Pfizer gave Ranbaxy 6 months exclusivity to market generic Lipitor in the U.S., though the manufacturer has yet to resolve a dispute with the FDA and the Justice Department over a restriction on exports from two of their plants in India. Generic Lipitor is expected to generate $750 million in sales for Ranbaxy during the exclusivity period, although it will face competition from an authorized version by Watson Pharmaceuticals Inc. Pfizer will also try to introduce a nonprescription form of Lipitor to help lessen the anticipated decline in sales.
To subscribe to e-Connect, send your name, address, and email address to us by clicking here. U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.